Batu Biologics Launches Crowdfunding Campaign To Complete Preclinical Testing For Vallovax Cancer Therapy
6/19/2014 11:36:40 AM
SAN DIEGO--(BUSINESS WIRE)--Batu Biologics announced today the launch of its first crowdfunding campaign with Indiegogo seeking to raise $100,000 dollars to complete preclinical testing for VallovaxTM, an immunotherapeutic product which selectively kills blood vessels feeding the tumor.
Help employers find you! Check out all the jobs and post your resume.
comments powered by